[ 1 ] Borowitz M, Bene MC, Harris NL, et al. Acute leukemias of ambiguous lineage[M]//Swerdlow SH, Campo E, Harris NL, et al. World Health Organization classification of tumors: pathology and genetics of tumors of haematopoietic and lymphoid tissues. Lyon, IARC Press, 2008: 150-155.
[ 3 ] Brüggemann M, Schrauder A, Raff T, et al. Standardized MRD quantification in European ALL trials: proceedings of the second international symposium on MRD assessment in Kiel, Germany, 18？20 September 2008[J]. Leukemia, 2010, 24 (3): 521-535.
[5]
[ 4 ] Pedreira CE, Costa ES, Barrena S, et al. Generation of flow cytometry data files with a potentially infinite number of dimensions[J]. Cytometry A, 2008, 73 (9): 834-846.
[6]
[ 5 ] Weinberg OK, Arber DA. Mixed-phenotype acute leukemia: historical overview and a new definition[J]. Leukemia, 2010, 24(11): 1844-1851.
[7]
[ 6 ] Craig FE, Foon KA. Flow cytometric immunophenotyping for hematologic neoplasms[J]. Blood, 2008, 111(8): 3941-3967.
[8]
[ 7 ] Matutes E, Pickl WF, van’t VeerM, et al. Mixed-phenotype acute leukemia: clinical and laboratory features and classification outcome in 100 patients defined according to the WHO 2008[J]. Blood, 2011, 117(11): 3163-3171.
[9]
[ 8 ] van den Ancker W, Terwijn M, Westers TM, et al. Acute leukemias of ambiguous lineage: diagnostic consequences of the WHO 2008 classification [J]. Leukemia, 2010, 24(7): 1392-1396.
[10]
[ 9 ] Wood B. 9-color and 10-color flow cytometry in the clinical laboratory[J]. Arch Pathol Lab Med, 2006, 130(5): 680-690.
[11]
Preffer F, Dombkowski D. Advances in complex multiparameter flow cytometry technology: applications in stem cell research[J]. Cytometry B Clin Cytom, 2009, 76(5): 295-314.
Mahnke YD, Roederer M. Optimizing a multicolor immunophenotyping assay[J]. Clin Lab Med, 2007, 27(3): 469-487.
[14]
Chattopadhyay PK, Hogerkorp CM, Roederer M. A chromatic explosion: the development and future of multiparameter flow cytometry[J]. Immunology, 2008, 125(4): 441-449.
